Hainan Poly Pharm Co (SZSE:300630) Other Income (Minority Interest) : ¥0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. Hainan Poly Pharm Co's Other Income (Minority Interest) for the three months ended in Sep. 2023 was ¥0 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2023 was ¥0 Mil.

Hainan Poly Pharm Co Other Income (Minority Interest) Historical Data

The historical data trend for Hainan Poly Pharm Co's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Other Income (Minority Interest) Chart

Hainan Poly Pharm Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Income (Minority Interest)

Get a 7-Day Free Trial

Hainan Poly Pharm Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Income (Minority Interest)	Get a 7-Day Free Trial															-	-	-	-	-

Hainan Poly Pharm Co Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Hainan Poly Pharm Co (SZSE:300630) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Hainan Poly Pharm Co (SZSE:300630) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Other Income (Minority Interest)

Traded in Other Exchanges

N/A

Address

No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051

Website

http://www.hnpoly.com

Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Executives

Fan De Zhu	Independent director
Xie Hui Fang	Supervisors
Pu Jian	Executives
Xu Zhao	Securities Affairs Representative
Shen Shi Hua	Executives
Zhou Mao	Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines